BioSpace News Archive

Press Releases

Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer

December 3, 2024

·

1 min read

Deerfield - Circa June 2019: Takeda Pharmaceutical Company. Takeda recently acquired Irish drugmaker Shire I

Collaboration

Takeda Puts Up to $1.3B on the Line for Keros’ Blood Cancer Anemia Drug

Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a formidable challenge to Bristol Myers Squibb’s Reblozyl.

December 3, 2024

·

2 min read

·

Tristan Manalac

Press Releases

Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne

December 3, 2024

·

6 min read

Press Releases

ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine

December 3, 2024

·

6 min read

Press Releases

Saghmos Therapeutics Announces Presentation at the Citi Global Healthcare Conference

December 3, 2024

·

2 min read

Press Releases

Enpro to Present at the Sidoti December Small Cap Conference

December 3, 2024

·

1 min read

Pill with human brains on isolated pastel pink background. Minimal abstract concept. Lack of wisdom and memory or treatment psychiatric or psychological disorders. Creative idea of mental illness or health care. Flat lay.

Neuroscience

Intra-Cellular Eyes Depression Approval for Caplyta as Stock Flies Under the Radar

Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening up an additional $1 billion in sales. Still, the stock remains “cheap,” according to Jefferies analysts.

December 3, 2024

·

4 min read

·

Annalee Armstrong

Press Releases

Former Merck USA President Joins Klotho Neurosciences’ Board of Directors

December 3, 2024

·

4 min read

Press Releases

Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation